Microregional effects of gemcitabine in HCT-116 xenografts

Cancer Research
Lynsey A HuxhamAndrew I Minchinton

Abstract

To examine the tumor microregional effects after gemcitabine administration to mice, we mapped the location of proliferating and hypoxic cells relative to vasculature in human colon cancer xenografts. The S-phase marker bromodeoxyuridine was used as a surrogate of drug effect and administered 2 hours before tumor excision, whereas vessel position and perfusion were assessed via staining for CD31 and intravenous injection of carbocyanine, respectively. Hypoxia was detected using pimonidazole. Images of the four markers were overlaid to reveal the spatial relationship between proliferation, vasculature, and hypoxia and to examine the microregional effects. Within 1 day after administration of 240 mg/kg of gemcitabine, proliferation throughout the tumor was completely inhibited. Over time, a reemergence of dividing cells occurred in relation to the distance from vasculature. Microregional analysis revealed that cells located distal to vasculature commenced cycling sooner than cells located proximal to vasculature. A similar trend was seen after multiple doses of gemcitabine (40 mg/kg on days 1, 4, 7, and 10). The possibility that the effect of gemcitabine could be attributed to changes in oxygenation was discounted after examining...Continue Reading

References

Jan 1, 1997·Acta Oncologica·A I MinchintonK H Fryer
Jul 4, 2001·International Journal of Cancer. Journal International Du Cancer·P CappellaP Ubezio

❮ Previous
Next ❯

Citations

Apr 6, 2012·Archives of Pharmacal Research·Soo-Yeon KimHyo-Jeong Kuh
Jun 21, 2005·Nature Reviews. Cancer·John J Kim, Ian F Tannock
Jul 25, 2006·Nature Reviews. Cancer·Andrew I Minchinton, Ian F Tannock
Dec 8, 2010·Nature Reviews. Clinical Oncology·Alberto OcanaIan F Tannock
Mar 12, 2011·Proceedings of the National Academy of Sciences of the United States of America·Foster C GonsalvesRamanuj DasGupta
Sep 27, 2007·Journal of the National Cancer Institute·Olivier TrédanIan F Tannock
Jan 3, 2012·International Journal of Molecular Medicine·Kiyoshi OkamotoKohei Sawada
Jul 13, 2013·Chinese Journal of Cancer·Christopher P GuiseKe Ding
Nov 21, 2007·Microvascular Research·Lynsey A HuxhamAndrew I Minchinton
Feb 4, 2006·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Lynsey A HuxhamAndrew I Minchinton
Apr 24, 2015·Science Translational Medicine·Oliver JonasRobert Langer
Jul 24, 2015·Cancer Biotherapy & Radiopharmaceuticals·Robin M KramerJohn L Humm
Dec 17, 2014·The Journal of Experimental Medicine·Iva KulicAly Karsan
May 27, 2010·British Journal of Cancer·P WorkmanUNKNOWN Committee of the National Cancer Research Institute
Sep 10, 2018·Clinical & Experimental Metastasis·Jennifer Hazel Elizabeth BakerAndrew Ivor Minchinton
May 28, 2019·Cancer Biology & Therapy·Xinjian MaoKevin O Hicks
Jun 28, 2014·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Dae Hwan ShinJin-Seok Kim
Mar 19, 2008·Molecular Cancer Therapeutics·Berta LaquenteFrancesc Viñals
Jan 26, 2013·Molecular Cancer Therapeutics·Jasdeep K SaggarIan F Tannock
Feb 14, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jasdeep K Saggar, Ian F Tannock
May 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alastair H KyleAndrew I Minchinton
Oct 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Joseph D MocanuFei-Fei Liu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.